The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Insomnia Therapy Market Research Report 2025
Synopsis
The Insomnia Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insomnia Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insomnia Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck & Co.
Sanofi
Pfizer
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Eisai, Co. Ltd.
Meda Consumer Healthcare
Pernix Therapeutics
Vanda Pharmaceuticals
ECR Pharmaceuticals
Fidia Farmaceutici
Dainippon Sumitomo
Biocodex
Eli Lilly and Company
Ebb Therapeutics
Segment by Type
Non-pharmacological Therapy
Pharmacological Therapy
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Insomnia Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Insomnia Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insomnia Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insomnia Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck & Co.
Sanofi
Pfizer
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Eisai, Co. Ltd.
Meda Consumer Healthcare
Pernix Therapeutics
Vanda Pharmaceuticals
ECR Pharmaceuticals
Fidia Farmaceutici
Dainippon Sumitomo
Biocodex
Eli Lilly and Company
Ebb Therapeutics
Segment by Type
Non-pharmacological Therapy
Pharmacological Therapy
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Insomnia Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Non-pharmacological Therapy
1.2.3 Pharmacological Therapy
1.3 Market by Application
1.3.1 Global Insomnia Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Insomnia Therapy Market Perspective (2019-2030)
2.2 Insomnia Therapy Growth Trends by Region
2.2.1 Global Insomnia Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Insomnia Therapy Historic Market Size by Region (2019-2024)
2.2.3 Insomnia Therapy Forecasted Market Size by Region (2025-2030)
2.3 Insomnia Therapy Market Dynamics
2.3.1 Insomnia Therapy Industry Trends
2.3.2 Insomnia Therapy Market Drivers
2.3.3 Insomnia Therapy Market Challenges
2.3.4 Insomnia Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Insomnia Therapy Players by Revenue
3.1.1 Global Top Insomnia Therapy Players by Revenue (2019-2024)
3.1.2 Global Insomnia Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Insomnia Therapy Revenue
3.4 Global Insomnia Therapy Market Concentration Ratio
3.4.1 Global Insomnia Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Therapy Revenue in 2023
3.5 Insomnia Therapy Key Players Head office and Area Served
3.6 Key Players Insomnia Therapy Product Solution and Service
3.7 Date of Enter into Insomnia Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Therapy Breakdown Data by Type
4.1 Global Insomnia Therapy Historic Market Size by Type (2019-2024)
4.2 Global Insomnia Therapy Forecasted Market Size by Type (2025-2030)
5 Insomnia Therapy Breakdown Data by Application
5.1 Global Insomnia Therapy Historic Market Size by Application (2019-2024)
5.2 Global Insomnia Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Insomnia Therapy Market Size (2019-2030)
6.2 North America Insomnia Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Insomnia Therapy Market Size by Country (2019-2024)
6.4 North America Insomnia Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Insomnia Therapy Market Size (2019-2030)
7.2 Europe Insomnia Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Insomnia Therapy Market Size by Country (2019-2024)
7.4 Europe Insomnia Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Therapy Market Size (2019-2030)
8.2 Asia-Pacific Insomnia Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Insomnia Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Insomnia Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Insomnia Therapy Market Size (2019-2030)
9.2 Latin America Insomnia Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Insomnia Therapy Market Size by Country (2019-2024)
9.4 Latin America Insomnia Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Therapy Market Size (2019-2030)
10.2 Middle East & Africa Insomnia Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Insomnia Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Insomnia Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck & Co.
11.1.1 Merck & Co. Company Detail
11.1.2 Merck & Co. Business Overview
11.1.3 Merck & Co. Insomnia Therapy Introduction
11.1.4 Merck & Co. Revenue in Insomnia Therapy Business (2019-2024)
11.1.5 Merck & Co. Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Insomnia Therapy Introduction
11.2.4 Sanofi Revenue in Insomnia Therapy Business (2019-2024)
11.2.5 Sanofi Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Insomnia Therapy Introduction
11.3.4 Pfizer Revenue in Insomnia Therapy Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Takeda Pharmaceutical Company Ltd.
11.4.1 Takeda Pharmaceutical Company Ltd. Company Detail
11.4.2 Takeda Pharmaceutical Company Ltd. Business Overview
11.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Introduction
11.4.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2019-2024)
11.4.5 Takeda Pharmaceutical Company Ltd. Recent Development
11.5 Purdue Pharmaceuticals L.P.
11.5.1 Purdue Pharmaceuticals L.P. Company Detail
11.5.2 Purdue Pharmaceuticals L.P. Business Overview
11.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Introduction
11.5.4 Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2019-2024)
11.5.5 Purdue Pharmaceuticals L.P. Recent Development
11.6 Eisai, Co. Ltd.
11.6.1 Eisai, Co. Ltd. Company Detail
11.6.2 Eisai, Co. Ltd. Business Overview
11.6.3 Eisai, Co. Ltd. Insomnia Therapy Introduction
11.6.4 Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2019-2024)
11.6.5 Eisai, Co. Ltd. Recent Development
11.7 Meda Consumer Healthcare
11.7.1 Meda Consumer Healthcare Company Detail
11.7.2 Meda Consumer Healthcare Business Overview
11.7.3 Meda Consumer Healthcare Insomnia Therapy Introduction
11.7.4 Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2019-2024)
11.7.5 Meda Consumer Healthcare Recent Development
11.8 Pernix Therapeutics
11.8.1 Pernix Therapeutics Company Detail
11.8.2 Pernix Therapeutics Business Overview
11.8.3 Pernix Therapeutics Insomnia Therapy Introduction
11.8.4 Pernix Therapeutics Revenue in Insomnia Therapy Business (2019-2024)
11.8.5 Pernix Therapeutics Recent Development
11.9 Vanda Pharmaceuticals
11.9.1 Vanda Pharmaceuticals Company Detail
11.9.2 Vanda Pharmaceuticals Business Overview
11.9.3 Vanda Pharmaceuticals Insomnia Therapy Introduction
11.9.4 Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2019-2024)
11.9.5 Vanda Pharmaceuticals Recent Development
11.10 ECR Pharmaceuticals
11.10.1 ECR Pharmaceuticals Company Detail
11.10.2 ECR Pharmaceuticals Business Overview
11.10.3 ECR Pharmaceuticals Insomnia Therapy Introduction
11.10.4 ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2019-2024)
11.10.5 ECR Pharmaceuticals Recent Development
11.11 Fidia Farmaceutici
11.11.1 Fidia Farmaceutici Company Detail
11.11.2 Fidia Farmaceutici Business Overview
11.11.3 Fidia Farmaceutici Insomnia Therapy Introduction
11.11.4 Fidia Farmaceutici Revenue in Insomnia Therapy Business (2019-2024)
11.11.5 Fidia Farmaceutici Recent Development
11.12 Dainippon Sumitomo
11.12.1 Dainippon Sumitomo Company Detail
11.12.2 Dainippon Sumitomo Business Overview
11.12.3 Dainippon Sumitomo Insomnia Therapy Introduction
11.12.4 Dainippon Sumitomo Revenue in Insomnia Therapy Business (2019-2024)
11.12.5 Dainippon Sumitomo Recent Development
11.13 Biocodex
11.13.1 Biocodex Company Detail
11.13.2 Biocodex Business Overview
11.13.3 Biocodex Insomnia Therapy Introduction
11.13.4 Biocodex Revenue in Insomnia Therapy Business (2019-2024)
11.13.5 Biocodex Recent Development
11.14 Eli Lilly and Company
11.14.1 Eli Lilly and Company Company Detail
11.14.2 Eli Lilly and Company Business Overview
11.14.3 Eli Lilly and Company Insomnia Therapy Introduction
11.14.4 Eli Lilly and Company Revenue in Insomnia Therapy Business (2019-2024)
11.14.5 Eli Lilly and Company Recent Development
11.15 Ebb Therapeutics
11.15.1 Ebb Therapeutics Company Detail
11.15.2 Ebb Therapeutics Business Overview
11.15.3 Ebb Therapeutics Insomnia Therapy Introduction
11.15.4 Ebb Therapeutics Revenue in Insomnia Therapy Business (2019-2024)
11.15.5 Ebb Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
